Showing results (1281-1290 of 1,454) with videos related to

Sort By:
Pageof 146
The Journal of Clinical Endocrinology and Metabolism|July 15, 2011
Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphyKathryn S King, Clara C Chen, Dimitrios K Alexopoulos, et al.
Plos Pathogens|March 8, 2014
Porphyromonas gingivalis and Treponema denticola exhibit metabolic symbiosesKheng H Tan, Christine A Seers, Stuart G Dashper, et al.
Computer Methods and Programs in Biomedicine|September 14, 2025
Integration of nested cross-validation, automated hyperparameter optimization, high-performance computing to reduce and quantify the variance of test performance estimation of deep learning modelsPaul Calle, Averi Bates, Justin C Reynolds, et al.
Sleep Medicine Reviews|February 12, 2026
Understanding delayed sleep-wake phase disorder (DSWPD): Mechanisms, comorbidities, and evolving approaches to diagnosis and treatmentGorica Micic, Amy C Reynolds, Andrew J K Phillips, et al.
American Journal of Nephrology|April 10, 2019
Open-Label Clinical Trials of Oral Pulse Dexamethasone for Adults with Idiopathic Nephrotic SyndromeMonique E Cho, Mary H Branton, David A Smith, et al.
Journal of Surgical Oncology|December 26, 2002
Role of metastasectomy in the management of thyroid carcinoma: the NIH experienceHo Pak, Loukas Gourgiotis, Wen-I Chang, et al.
Advances in Oto-Rhino-Laryngology|March 2, 2011
Hereditary hearing loss with thyroid abnormalitiesByung Yoon Choi, Julie Muskett, Kelly A King, et al.
Chemistry & Biology|March 26, 2013
Bayesian models leveraging bioactivity and cytotoxicity information for drug discoverySean Ekins, Robert C Reynolds, Hiyun Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 30, 2014
Macrophage depletion abates Porphyromonas gingivalis-induced alveolar bone resorption in miceRoselind S Lam, Neil M O'Brien-Simpson, Jason C Lenzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2014
Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancerT S Mok, S L Geater, N Iannotti, et al.
Pageof 146